Takara Bio Inc. plans to implement a share consolidation at the extraordinary general meeting of shareholders on May 20, 2026, consolidating 15,332,374 shares into one share, reducing the number of issued shares from 120,415,294 shares to 6 shares. The tender offer price is set at \u00a51,150, and delisting is scheduled for June 12, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4974","jir_company_name":"Takara Bio Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-04-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/4974-20260427-02.pdf","jir_short_summary":"Takara Bio Inc. plans to implement a share consolidation at the extraordinary general meeting of shareholders on May 20, 2026, consolidating 15,332,374 shares into one share, reducing the number of issued shares from 120,415,294 shares to 6 shares. The tender offer price is set at \u00a51,150, and delisting is scheduled for June 12, 2026.","jir_summary":"### Overview of Share Consolidation and Tender Offer\nTakara Bio Inc. has been acquired at 87.27% of shares as of April 13, 2026, through a tender offer by its parent company, Takara Holdings Inc. In response, an extraordinary general meeting of shareholders will be held on May 20, 2026, to propose the consolidation of 15,332,374 shares into one share. This will drastically reduce the number of issued shares from approximately 120 million shares to 6 shares, leaving only the tender offeror as shareholders. The tender offer price is set at \u00a51,150, raised from the initial \u00a5950 after several rounds of negotiation.\n\n### Outlook on Delisting and Amendments to the Articles of Incorporation\nFollowing the share consolidation, the company will meet the delisting criteria of the Tokyo Stock Exchange and will be designated as a securities to be delisted from May 20 to June 11, 2026, with delisting scheduled for June 12, 2026. As a result, trading on the relevant market will no longer be possible. Concurrently, partial amendments to the articles of incorporation are planned, including abolition of the designation of the number of shares per unit and changes to the total number of authorized shares. These amendments will become effective on June 16, 2026, subject to approval at the shareholders meeting. These measures are aimed at the full subsidiary formation via the tender offeror, with fairness measures implemented by an independent special committee and a third-party valuation institution to protect shareholders\u2019 interests.","jir_financial_highlights":"Share Consolidation Ratio: Consolidation of 15,332,374 shares into one share (Number of issued shares expected to decrease from 120,415,294 shares to 6 shares)\nTender Offer Price: \u00a51,150 (Tender offer price raised from the initial \u00a5950 through negotiations)\nDelisting Date: 2026-06-12 (Delisting will make trading on the Tokyo Stock Exchange Prime Market impossible)","jir_category":"","jir_hashtags":"#TakaraBioInc, #CapitalPolicy, #ShareConsolidation, #Delisting","jir_key_figures":"Share Consolidation Ratio: Consolidation of 15,332,374 shares into one share\nNumber of Issued Shares: Expected reduction from 120,415,294 shares to 6 shares\nTender Offer Price: \u00a51,150 (approx. 40% premium)","jir_meta_title":"[Takara Bio] Announces Share Consolidation and Delisting | June 2026","jir_meta_description":"Takara Bio will implement a share consolidation on May 20, 2026, significantly reducing the number of issued shares. The tender offer price is \u00a51,150, representing approximately a 40% premium. Delisting from the Tokyo Stock Exchange is scheduled for June 12.","jir_og_title":"[Takara Bio] Announces Share Consolidation and Delisting | June 2026","jir_og_description":"Takara Bio will reduce its number of issued shares to 6 through share consolidation, with a tender offer price of \u00a51,150. Delisting is planned for June 12, 2026.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9678,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-42903","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n